National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES.

1961. No. 137.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1961.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1961.

Dated this 26th day of October, 1961.

DE L’ISLE

Governor-General.

By His Excellency’s Command,

(sgd) Donald A. Cameron

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits)

Regulations. 

Commencement.

1. These Regulations shall come into operation on the first day of November, 1961.

First, Second Third, Fourth and Fifth Schedules.

2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

First Schedule.

Regulation 10.

DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS, OR USED IN, PHARMACEUTICAL BENEFITS EXCEPT AS SPECIALLY PROVIDED.

Absorbable Gelatin Sponge.	Antimony Sodium Tartrate.
Acetazolamide.	Apomorphine Hydrochloride.
Acetomenaphthone.	Azovan Blue.
Adrenaline Acid Tartrate.	Bacillus Calmette-Guerin Vaccine.
Alcohol.	Bemegride.
Amethocaine Injection.	Benzhexol Hydrochloride.
Amodiaquine Hydrochloride.	Bismuth Oxychloride.
Amphetamine.	Bismuth Oxychloride Injection.
Amphetamine Sulphate.	Bismuth Sodium Tartrate.
Amylobarbitone.	Busulphan.
Amylobarbitone Sodium.	Butobarbitone.
Amylobarbitone Sodium Tablets.	Calciferol.
Anise Oil.	Camphor Water.
Antimony Potassium Tartrate.	Caraway.

* Notified in the Commonwealth Gazette on 27th October, 1961.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; and 1961, No. 59.

9145/61.—Price 1s. 10/4.10.1961.

First Schedule—continued.

Carbachol.

Carbimazole.

Carbon Dioxide.

Cardamom Fruit.

Catgut, sterilized surgical.

Cellulose Oxidized.

Chlorcyclizine Hydrochloride.

Chorionic Gonadotrophin.

Chloroform.

Chloroform Spirit.

Chloroform Water.

Chloroquine Phosphate.

Chloroquine Sulphate.

Chlorothiazide.

Chloroxylenol.

Chlortetracycline Injection.

Cinchocaine Hydrochloride.

Cinnamon.

Cinnamon Oil.

Cinnamon Water, concentrated.

Cochineal.

Colchicine.

Coriander.

Coriander Oil.

Corticotrophin.

Cresol.

Cyanocobalamin.

Cyclobarbitone.

Cyclopropane.

Dapsone.

Dexamphetamine Sulphate.

Dextran Injection.

Dextran Sulphate.

Dextran Sulphate Injection.

Diethylcarbamazine Citrate.

Digitalis Leaf.

Dill Oil.

Dill Water, concentrated.

Dimercaprol.

Diodone Injection.

Dithranol.

Emetine and Bismuth Iodide.

Emetine Hydrochloride.

Ergometrine Maleate.

Ether Anaesthetic.

Ether Solvent.

Ether Vinyl.

Ethinyloestradiol.

Ethisterone.

Ethopropazine Hydrochloride.

Ethyl Biscoumacetate.

Ethyl Chloride.

Ethylenediamine Hydrate.

Gallamine Triethiodide.

Gallamine Injection.

Gentian.

Gentian Compound Infusion.

Ginger.

Ginger Syrup.

Halothane.

Hamamelis.

Helium.

Heparin.

Hexamethonium Tartrate.

Histamine Acid Phosphate.

Human Blood, whole.

Human Red Blood Corpuscles, concentrated.

Human Fibrin Foam.

Human Fibrinogen.

Human Gamma Globulin.

Human Gamma Globulin Injection.

Human Serum, dried.

Human Serum, liquid.

Human Plasma, dried.

Human Thrombin.

Hydrocortisone Acetate.

Hydrocortisone Acetate Ointment.

Hydrocortisone Hydrogen Succinate.

Hydrocortisone Ointment.

Hydrogen Peroxide Solution, strong.

Hydroxychloroquine Sulphate.

Hyoscine Eye Ointment.

Hyoscyamus.

Iodised Oil Injection.

Iodoxyl.

Iopanoic Acid.

Iopanoic Acid Tablets.

Ipecacuanha.

Ipecacuanha, prepared.

Isoniazid.

Lead Acetate.

Lead Monoxide.

Lemon Peel, dried.

Lemon Peel, fresh.

Lemon Tincture.

Lemon Syrup.

Leptazol.

Lignocaine and Adrenaline Injection.

Lignocaine Hydrochloride.

Lignocaine Hydrochloride Injection.

Liothyronine Sodium.

Liothyronine Tablets.

Liquorice Liquid Extract.

Lucanthone Hydrochloride.

Male Fern.

Maleic Acid.

Mannitol.

Mepacrine Hydrochloride.

Mephenesin.

Mephenesin Injection.

Mercaptopurine.

Mercuric Oxide, yellow.

Mercury.

Mersalyl Acid.

Methadone Hydrochloride.

Methoin.

Methylated Spirits, industrial.

Methyltestosterone.

Methylamphetamine Hydrochloride.

Methylthiouracil.

Mustine Hydrochloride.

Nalorphine Hydrobromide.

First Schedule—continued.

Naphazoline Hydrochloride.

Neostigmine Bromide.

Neostigmine Methylsulphate.

Nicotinic Acid.

Nikethamide.

Nitrous Oxide.

Nux Vomica.

Oestradiol Benzoate.

Opium.

Opium, powdered.

Orange Peel, dried bitter.

Orange Peel, fresh bitter.

Orange Tincture.

Orange Syrup.

Ouabain.

Oxygen.

Oxytetracycline Dihydrate.

Paramethadione.

Pentamidine Injection.

Pentamidine Isethionate.

Peppermint Oil.

Peppermint Water, concentrated.

Peppermint Spirit.

Pethidine Tablets.

Phenindamine Tartrate.

Phenindione.

Pheniodol.

Phenolphthalein Tablets.

Phenolsulphonphthalein.

Phytomenadione.

Phytomenadione Capsules.

Picrotoxin.

Poliomyelitis Vaccine.

Potassium Perchlorate.

Prednisone Acetate.

Primaquine Phosphate.

Primidone.

Probenecid.

Procyclidine Hydrochloride.

Procaine and Adrenaline Injection.

Progesterone.

Proguanil Hydrochloride.

Propylene Glycol.

Propyliodone.

Propyliodone Injection.

Propyliodone Oily Injection.

Propyl Thiouracil.

Pyridostigmine Bromide.

Pyrimethamine.

Pyrimethamine Tablets.

Quillaia.

Rosemary Oil.

Senna Leaf.

Soda Lime.

Sodium Antimonylgluconate.

Sodium Antimonylgluconate Injection.

Sodium Aurothiomalate.

Sodium Radio-iodide (131 I) Injection.

Sodium Radio-iodide (131 I) Solution.

Sodium Radiophosphate (82 P) Injection.

Sodium Radiophosphate (82 P) Solution.

Sodium Stibogluconate.

Sodium Stibogluconate Injection.

Solapsone.

Solapsone Tablets.

Stibophen.

Sucrose.

Sulphadimidine Sodium.

Suramin.

Suxamethonium Bromide.

Suxamethonium Chloride.

Suxamethonium Chloride Injection.

Syrup.

Testosterone.

Tetrachloroethylene.

Tetracycline Injection.

Thiomersal.

Thiopentone Sodium.

Thiopentone Injection.

Thyroid.

Thyroxine Sodium.

Tolazoline Hydrochloride.

Tolbutamide.

Tolu Syrup.

Trichloroethylene.

Tryparsamide.

Tuberculin, old.

Tuberculin Purified Protein Derivative.

Tubocurarine Chloride.

Tubocurarine Injection.

Typhoid-Paratyphoid A and B and Cholera Vaccine.

Typhoid-Paratyphoid A and B and Tetanus Vaccine.

Vanillin.

Yellow Fever Vaccine.

 

Second Schedule.

Regulation 10 (3.).

DRUGS AND MEDICINAL PREPARATIONS THAT ARE PHARMACEUTICAL BENEFITS ONLY WHEN PRESCRIBED FOR USE IN A DETERMINED FORM OR IN ALLOWABLE COMPOUNDS.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Acetone B.P.C.......................................................	Zinc Sulphate B.P. with Sulphurated Potash B.P.C., Acetone B.P.C., Glycerin B.P. and Distilled Water B.P.
	Magenta B.P.C. with Boric Acid B.P., Phenol B.P., Resorcinol B.P., Acetone B.P.C., Industrial Methylated Spirits B.P. and Water
Dried Aluminium Hydroxide Gel. B.P.	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Aluminium Hydroxide Gel. B.P.........................	Aluminium Hydroxide Gel. B.P. with Light Magnesia B.P.
	Aluminium Hydroxide Gel. B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P.
Aluminium Powder..............................................	Aluminium Powder with Zinc Oxide B.P. and Liquid Paraffin B.P.
Amiphenazole Hydrobromide............................	—
Amiphenazole Hydrochloride A.P.F. 1955	—
Aneurine Hydrochloride B.P..............................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D.
Ascorbic Acid B.P................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Bacitracin B.P........................................................	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
	Bacitracin B.P. with Ophthalmic Phosphate Buffer Solution
	Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P.
Bendrofluazide.....................................................	—
Benethamine Penicillin........................................	Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Benzalkonium Chloride.......................................	—
Benzathine Penicillin B.P....................................	Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin B.P............................................	Fortified Procaine Penicillin Injection B.P.
	Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
	Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin Sodium B.P.............................	Streptomycin Sulphate B.P. with Benzylpenicillin Sodium B.P.
	Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Bismuth Subnitrate B.P.C...................................	Resorcinol B.P. with Bismuth Subnitrate B.P.C. Zinc Oxide B.P., Starch B.P., Cade Oil B.P., Wool Fat B.P., Sodium Metabisulphite, Water, Hard Paraffin B.P. and Yellow Soft Paraffin B.P.
Butabarbital Sodium............................................	—

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Carbromal B.P.......................................................	Pentobarbitone Sodium B.P. with Carbromal B.P.
Chloramphenicol B.P...........................................	Chloramphenicol B.P. with Borate Buffer and Sterile Distilled Water
	Chloramphenicol B.P. with Propylene Glycol B.P.
	Chloramphenicol B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Chlorpromazine Hydrochloride B.P..................	—
Chlortetracycline Calcium..................................	—
Chlortetracycline Hydrochloride B.P................	Chlortetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Oil of Citronella....................................................	Dicophane B.P. with Emulsifying Wax B.P., Xylene B.P.C. 1949, Oil of Citronella and Water
Clemizole...............................................................	—
Cortisone Acetate B.P..........................................	—
Demethylchlortetracycline Hydrochloride	—
Dexamethasone Sodium Phosphate..................	—
Dextrochlorpheniramine Maleate.....................	—
Dicyclomine Hydrochloride...............................	—
Dienostrol B.P.......................................................	—
Diethyl Dithiolisophthalate.................................	—
Diiodohydroxyquinoline B.P..............................	—
Diphenylthiourea..................................................	—
Diphtheria and Pertussis Vaccine B.P.	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Diphtheria Vaccine B.P.......................................	Diphtheria and Pertussis Vaccine B.P.
	Diphtheria, Tetanus and Pertussis Vaccine B.P.
	Diphtheria and Tetanus Vaccine B.P.
Diphtheria and Tetanus Vaccine B.P................	—
Ergotamine Tartrate B.P......................................	Ergotamine Tartrate B.P. with Caffeine B.P.
Erythromycin B.P.................................................	—
Ethotoin..................................................................	—
Ferrous Aminoacetosulphate.............................	—
Ferrous Succinate.................................................	—
Glucose Indicator.................................................	—
Griseofulvin...........................................................	—
Guanethidine Sodium..........................................	—
Haemophilus Influenza Bacterial Serum	—
Hamamelis Dry Extract.......................................	Hamamelis Dry Extract with Zinc Oxide B.P. and Theobroma Oil B.P.
Hexocyclium Methyl Sulphate..........................	—
Hydrocortisone B.P..............................................	—
Hydrocortisone Sodium Succinate....................	—
Isoprenaline Hydrochloride................................	—
Isopropamide Iodide............................................	—
Levallorphan Tartrate..........................................	Levallorphan Tartrate with Pethidine Hydrochloride B.P.
Lofenalac...............................................................	—
Meclozine Hydrochloride B.P.C........................	—
Mercuric Oxide Eye Ointment B.P....................	—
Methazolamide.....................................................	—
Methscopolamine Bromide................................	—
Methyclothiazide..................................................	—
Methylphenobarbitone B.P.C.............................	—
Methylprednisolone.............................................	—
Naphazoline Nitrate B.P......................................	Antazoline Hydrochloride B.P. with Naphazoline Nitrate B.P.
Neomycin Sulphate B.P., Eye Drops................	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
	Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P.

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Nicotinamide B.P.......................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D.
Oestrone......................................................................	—
Oleandomycin............................................................	Tetracycline with Oleandomycin
Oleoresin Capsicum..................................................	Bile Salts with Cascara Sagrada B.P., Phenolphthalein B.P. and Oleoresin Capsicum
Oxyphencyclimine Hydrochloride.........................	—
Oxyphenonium Bromide..........................................	—
Oxytetracycline Hydrochloride B.P.......................	Oxytetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Papaveretum B.P.C...................................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Pancreatin B.P............................................................	—
Pempidine Tartrate....................................................	—
Pentolinium Tartrate B.P..........................................	Pentolinium Tartrate B.P. with Ephedrine B.P.
Pethidine Hydrochloride B.P...................................	Pethidine Hydrochloride B.P. with Hyoscine Hydrobromide B.P.
	Pethidine Hydrochloride B.P. with Levallorphan Tartrate
Pertussis Vaccine B.P...............................................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
	Diphtheria and Pertussis Vaccine B.P.
Phenoxymethylpenicillin B.P..................................
Phenoxymethylpenicillin (Benzathine Salt)	—
Phenoxymethylpenicillin Calcium B.P.	—
Phenoxymethylpenicillin (Hydrabamine Salt)	—
Phenoxymethylpenicillin Potassium B.P.	—
Phenylephrine Hydrochloride B.P..........................	Phenylephrine Hydrochloride B.P. with Benzocaine B.P., Bismuth Subgallate, Zinc Oxide B.P., Hamamelis Dry Extract, Tannic Acid B.P., Menthol B.P., Boric Acid B.P. and Oil of Theobroma B.P.
Pipenzolate.................................................................	—
Polymyxin B. Sulphate B.P.....................................	Polymyxin B. Sulphate B.P. with Mucilage of Methylcellulose and Distilled Water B.P.
	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
	Polymyxin B. Sulphate B.P. with Ophthalmic Phosphate Buffer
	Polymyxin B. Sulphate B.P. with Acetic Acid B.P. and Propylene Glycol B.P.
	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Bacitracin B.P.
Prednisolone B.P........................................................	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
	Prednisolone B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Prednisolone Disodium Phosphate........................	—
Prednisone B.P...........................................................	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Procaine Hydrochloride B.P....................................	Procaine Hydrochloride B.P. in Normal Saline Tetracycline and Procaine Injection B.P.
Pyrazinamide.............................................................	—
Pyrvinium Pamoate..................................................	—
Pyridine Aldoxime Methiodide...............................	—
Pyrimido-Pyrimidine.................................................	—

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Pyrrolidino-Methyl-Tetracycline...........................	—
Rauwolfia Alkaloids................................................	—
Reserpine B.P............................................................	—
Riboflavine B.P.........................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D.
Sobee..........................................................................	—
Sodium Chloride B.P. with Potassium Chloride B.P. and Hydrated Calcium Chloride B.P. in Water for Injection B.P.	Sodium Chloride B.P. with Potassium Chloride B.P., Hydrated Calcium Chloride B.P., Water for Injection B.P. and Dextrose B.P.
Compound Sodium Lactate Injection B.P.	Compound Sodium Lactate Injection B.P. with Dextrose B.P.
Sodium Lauryl Sulphate B.P..................................	Emulsifying Wax B.P.
Streptomycin Sulphate B.P.....................................	Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
	Benzylpenicillin Sodium B.P. with Streptomycin Sulphate B.P.
	Streptomycin Sulphate B.P. with Normal Saline
Sulphadimidine B.P.................................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphamerazine B.P.................................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphacetamide........................................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphathiazole..........................................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Tacrine.......................................................................	Tacrine with Morphine
Terpineol B.P............................................................	Solution of Chloroxylenol B.P.
Tetanus Vaccine B.P................................................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride B.P............................	Tetracycline Hydrochloride B.P. with Nystatin
	Tetracycline and Procaine Injection B.P.
	Tetracycline Hydrochloride B.P. with a buffering agent
	Tetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Tetracycline...............................................................	Tetracycline with Oleandomycin
Thenalidine................................................................	Thenalidine with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobroma Prepared B.P.C....................................	Calcium Gluconate B.P. with Sucrose B.P., Vanillin B.P. and Theobroma Prepared B.P.C.
Triamcinolone...........................................................	—
Trifluoperazine.........................................................	—
Tricyclamol Chloride...............................................	—
Tripelennamine Hydrochloride..............................	—
Troxidone B.P...........................................................	—
Typhoid Para-Typhoid A and B Vaccine B.P.	Typhoid Para-Typhoid A, B and C Vaccine B.P.
Tyrothricin.................................................................	Tyrothricin with a buffering agent
Concentrated Vitamin A Solution B.P.	Concentrated Vitamins A and D Solution B.P.
Concentrated Vitamin D Solution B.P.	Concentrated Vitamins A and D Solution B.P.
Vitamin D..................................................................

Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Xylene B.P.C. 1949.................................................	Dicophane B.P. with Emulsifying Wax B.P., Xylene B.P.C. 1949, Oil of Citronella and Water
Yellow Mercuric Oxide B.P...................................	Mercuric Oxide Eye Ointment B.P.

Third Schedule.

Regulation 11.

PHARMACEUTICAL BENEFITS ADDITIONAL TO PHARMACEUTICAL BENEFITS IN THE BRITISH PHARMACOPOEIA.

Acetazolamide Sodium.

Acetone, B.P.C.

Acetyl-Sulphamethoxypyridazine.

Aconite Liniment, B.P.C.

Acriflavine, B.P. 1948.

Adrenaline Hydrochloride Solution, B.P. 1953.

Adrenaline in Oil.

Adrenaline Mucate.

Agar, B.P.C.

Aloes Pill, B.P. 1948.

Aloin, B.P. 1953.

Aloxidone.

Aluminium Acetate Solution, B.P.C.

Aluminium Powder.

Amidopyrin, B.P.C. 1954.

Amiphenazole Hydrobromide.

Amiphenazole Hydrochloride, A.P.F. 1955.

Ammonium Acetate, Strong Solution, B.P. 1953.

Ammonium Bicarbonate, B.P. 1953.

Ammonium Bromide, B.P.C.

Amphotericin B.

Androstanolone.

Aromatic Ammonia Spirit, B.P. 1953.

Attapulgite.

Aurothioglucose.

Balsam of Peru, B.P.C.

Beeswax, Yellow, B.P.C.

Belladonna Suppository, B.P. 1948.

Bendrofluazide.

Benzalkonium Chloride.

Benzoinated Lard, B.P.C. 1954.

Bephenium Hydroxynaphthoate.

Bismuth Carbonate, B.P. 1953.

Bismuth Glycollylarsanilate.

Bismuth Subgallate, B.P. 1953.

Bismuth Subnitrate, B.P.C.

Bretylium Tosylate.

Brown Snake Antivenene.

Buchu Concentrated Infusion, B.P.C. 1954.

Butabarbital Sodium.

Butyl Aminobenzoate, B.P. 1953.

Caffeine Citrate, B.P.C.

Calamine Cream, A.P.F.

Calcium Aurothiomalate.

Calcium Di-Oxytetracycline.

Calcium Aminosalicylate, B.P.C.

Calcium Phosphate, B.P. 1953.

Calumba Concentrated Infusion, B.P. 1948.

Calumba Tincture, B.P. 1948.

Capsicum Ointment, B.P.C.

Capsicum Tincture, B.P.C.

Caramiphen Hydrochloride.

Cardamom Aromatic Tincture, B.P.C.

Catechu Tincture, B.P.C.

Cetyl Alcohol Compound.

Charcoal.

Chiniofon, B.P. 1948.

Chlorambucil.

Chlorazanil.

Chlormerodrin.

Chlorpheniramine Maleate.

Chlorpropamide.

Chlortetracycline Calcium.

Clemizole Hydrochloride.

Cloves, Concentrated Infusion, B.P.C. 1954.

Codeine, B.P.C. 1954.

Cod Liver Oil Emulsion, B.P. 1953.

Colchicine Salicylate.

Colocynth and Hyoscyamus Pill, B.P.C.

Colocynth, B.P.C.

Colocynth Compound Powder Extract, B.P.C.

Compound Effervescent Powder, B.P. 1953.

Creosote, B.P. 1953.

Crude Coal Tar.

Cyclophosphamide.

Cycloserine.

Cycrimine Hydrochloride.

D-Cycloserine.

Darrow’s Solution.

Demethylchlortetracycline Hydrochloride.

Desacetyl-Lanatoside, C.

Dexamethasone.

Dexamethasone Sodium Phosphate.

Dextran Iron.

Dextrin Iron.

Dextrochlorpheniramine Maleate.

Dichlorphenamide.

Dicyclomine Hydrochloride.

Diethazine Hydrochloride.

Dithiazanine Iodide.

Diethyl Dithiolisophthalate.

Digitoxin, B.P.C.

Dihydroergotamine.

Dihydromorphinone Hydrochloride, B.P.C. 1949.

Diphenylthiourea.

Diphtheria Toxoid Purified.

Disodium Diethylstilboestrol Diphosphate.

Disodium Dihydrogen Versenate.

Ephedrine Sulphate, B.P.C. 1954.

Ergot Liquid Extract, B.P.C. 1954.

Erythrityltetranitrate, B.P.C. 1949.

Erythromycin Glucoheptonate.

Erythromycin Propionate.

Erythromycin Stearate.

Ethotoin.

Ethoxzolamide.

Ethylidene Dicoumarin.

Ferric Chloride Solution, B.P.C.

Ferrous Aminoacetosulphate.

Ferrous Phosphate Compound Syrup, B.P.C.

Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.

Third Schedule—continued.

Ferrous Succinate.

Fludrocortisone Acetate.

Fluoxymesterone.

Formyl-Tetrahydropteroyl Glutamic Acid.

Fructose, B.P. 1948.

Gall with Opium Ointment, B.P.C.

Gelsemium Tincture, B.P.C.

Gentian Violet.

Glucose Indicator.

Glucose Liquid, B.P. 1953.

Glycerophosphates Compound Syrup, A.P.F.

Griseofulvin.

Guanethidine Sodium.

Guanethidine Sulphate.

Haemophilus Influenza Bacterial Serum.

Hamamelis Dry Extract.

Heparin Retard.

Hexachlorophene, 3% with Entsufon.

Hexachlohophene, 3% with Lissapol.

Hexachlorophene, 1.5% with Soap Solution.

Hexachlorothiazide.

Hexocyclium Methyl Sulphate.

Hexoestrol.

Hydrated Alumina Powder.

Hydrocalciferol.

Hydrocyanic Acid Dilute, B.P.C. 1954.

Hydroflumethiazide.

Hypophosphorous Acid Dilute, B.P.C.

Insulin Isophane (N.P.H.).

Insulin Special P (Pig).

Iodochlorhydroxyquinoline.

Iodoform B.P.C.

Iodoform Suppository, B.P. 1948.

Ipomoea Resin.

Iron Carbonate Saccharated, B.P.C.

Iron Oxide Saccharated.

Isoprenaline Hydrochloride.

Isopropamide Iodide.

Levallorphan Tartrate.

Levorphanol Tartrate, B.P.C.

Lobelia Ethereal Tincture, B.P.C.

Lofenalac.

Magenta, B.P.C.

Magnesium Bicarbonate Solution, B.P. 1948.

Mecamylamine.

Mecholyl Chloride.

Meclozine Hydrochloride, B.P.C.

Mercaptomerin Sodium.

Mercuric Chloride, B.P. 1953.

Mercurous Chloride Ointment, B.P. 1948.

Mercury Compound Ointment, B.P.C.

Methazolamide

Methenamine Mandelate.

Methicillin.

Methotrexate.

Methscopolamine Bromide.

Methyclothiazide.

Methyl Androstanolone.

Methyl Atropine Nitrate.

Methyl Prednisolone.

Methylandrostenediol.

Methylphenobarbitone, B.P.C.

Myrrh, B.P.C.

Myrrh Tincture, B.P.C.

Nicoumalone.

Nitrofurantoin.

Nitromin.

Nitrous Ether Spirit, B.P.C.

Norethandrolone.

Nux Vomica Extract, Dried, B.P. 1953.

Nystatin.

Oestradiol Dipropionate.

Oestrone.

Oleandomycin.

Oleoresin Capsicum.

Orange Peel Infusion Concentrated, B.P. 1948.

Orange Peel Infusion Concentrated, Compound, B.P.C.

Ox-Bile Extract, B.P. 1948.

Oxymel, B.P.C.

Oxymel of Squill, B.P.C.

Oxyphencyclimine Hydrochloride.

Oxyphenonium Bromide.

Pancrex 5.

Para-Aminosalicyclic Acid.

Paraben Ophthalmic Phosphate Buffer, A.P.F.

Paraben Ophthalmic Vehicle, A.P.F.

Papaveretum, B.P.C.

Pectin.

Pempidine Tartrate.

Benzylpenicillin in Oil.

Penicillin Benethamine.

Penicillinase.

Pentacrythritol Tetranitrate.

Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed).

Phenazone, B.P.C.

Phenoxymethylpenicillin (Benzathine Salt).

Phenoxymethylpenicillin (Hydrabamine Salt).

Phensuximide.

Phenylbutazone.

Phthalylsulphacetamide.

Pholcodine, B.P.C.

Pholcodine Citrate Syrup, B.P.C.

Pipenzolate.

Pituitary (Posterior Lobe).

Potash Suphurated, B.P.C.

Potassium Chlorate, B.P.C.

Prednisolone Disodium Phosphate.

Prednisolone Sodium Hemisuccinate.

Prophenpyridamine Para-Aminosalicylate.

Protamine Sulphate.

Protoveratrines A.

Pyrazinamide.

Pyridine Aldoxime Methiodide.

Pyridoxine Hydrochloride, B.P.C.

Pyrimido-Pyrimidine.

Pyrrolidino-Methyl-Tetracycline.

Pyrvinium Pamoate.

Quassia Tincture, B.F. 1948.

Rauwolfia Alkaloids.

Ristocetin.

Salicylazosulphapyridine.

Senega Concentrated Infusion, B.P.C.

Senna Compound Mixture, B.P.C.

Senna Leaf Concentrated Infusion, B.P.C.

Third Schedule—continued.

Siberian Fir Oil, B.P.C. 1949.

Silver Picrate, B.P.C. 1949.

Silver Protein Mild, B.P.C.

Soap Curd, B.P.C.

Soap Hard, B.P.C.

Sobee.

Sodium Calcium Edetate.

Sodium Carbonate Exsiccated, B.P.C.

Sodium Folate.

Sodium Lactate.

Sodium Nitrite, B.P.C.

Sodium Oleate Acid.

Sodium Tauroglycocholate.

Sorbolene, A.P.F.

Spiramycin.

Spironolactone.

Squill Tincture.

Squill Vinegar, B.P. 1948.

Strophanthus Tincture, B.P. 1948.

Strychnine, B.P.C.

Sulphacetamide.

Sulphadiazine Sodium.

Sulphadimethoxine.

Sulphamethoxypyridazine.

Sulphafurazole.

Sulphamethizole.

Sulphaphenazole.

Sulphathiazole.

Sulphapyridine, B.P.C.

Sulphuric Acid Dilute, B.P.C.

Sustanon.

Syntocinon.

Tacrine.

Talc Purified, B.P.C.

Testosterone Oenanthate.

Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed.

Tetracycline.

Thenalidine.

Theobromine, B.P.C.

Theobroma Prepared, B.P.C.

Thiacetazone.

Thiouracil, B.P. 1948.

Thyrotropin.

Tiger Snake Antivenene.

Tretamine.

Triamcinolone.

Tricyclamol Chloride.

Triethanolamine Trinitrate.

Triethylene Thiophosphoramide.

Trifluoperazine.

Trimetaphan Camphorsulphonate.

Trinitrophenol, B.P.C.

Triprolidine Hydrochloride.

Tyrothrycin.

Valerian Ammoniated Tincture, B.P.C.

Vasopressin Tannate in Oil.

Veriloid.

Vitamin A.

Vitamin D.

Vitamin K.

Xylene, B.P.C. 1949.

 

Fourth Schedule.

Regulation 12.

ADDITIVES.

Alcohol, B.P.

Amaranth Solution, A.P.F.

Amaranth Solution B.P.C. 1954.

Anise Oil, B.P.

Aniseed Water, concentrated, B.P.C.

Borate Buffer.

Camphor Water, B.P.

Camphor Water, concentrated, B.P.C. 1949.

Carmine Solution, A.P.F.

Chloroform, B.P.

Chloroform Spirit, B.P.

Chloroform Water, B.P.

Chloroform Water, concentrated, B.P.C.

Cinnamon Oil, B.P.

Cinnamon Water, concentrated, B.P.

Coconut Oil, B.P.C. 1949.

Coriander Oil, B.P.

Dill Oil, B.P.

Dill Water, concentrated, B.P.

Ether Anaesthetic, B.P.

Ether Solvent, B.P.

Honey Purified, B.P.C.

Industrial Methylated Spirit, B.P.

Lemon Tincture, B.P.

Lemon Syrup, B.P.

Liquorice Liquid Extract, B.P.

Methylcellulose, A.P.F.

Methylcellulose Mucilage, A.P.F.

Oil of Caraway, B.P.C.

Oil of Spike Lavender, B.P.C.

Orange Syrup, B.P.

Orange Tincture, B.P.

Peppermint Oil, B.P.

Peppermint Spirit, B.P.

Peppermint Water, concentrated, B.P.

Propylene Glycol, B.P.

Rosemary Oil, B.P.

Spirit of Aniseed, B.P.C. 1949

Spirit of Cajuput, B.P. 1948.

Spirit of Cinnamon, B.P.C. 1949.

Stearic Acid, B.P.C.

Sucrose, B.P.

Syrup, B.P.

Syrup of Ginger, B.P.

Syrup of Lemon, neutral, A.P.F.

Syrup, Red.

Syrup of Squill, B.P.C.

Syrup of Tolu, B.P.

Tincture of Cochineal, B.P. 1948.

Tincture of Cudbear, A.P.F. 1947.

Tincture of Quillaia, B.P.C.

Triethanolamine, B.P.C.

Vanillin, B.P.

Volatile Bitter Almond Oil, B.P. 1953.

Fifth Schedule.

Regulation 14.

PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS.

Pharmaceutical Benefit.		Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Amiphenazole Hydrobromide	As an antidote to barbiturate and other hypnotic poisons
Amiphenazole Hydrochloride A.P.F. 1955
Amphotericin B.......................................................		Systemic fungal infections
Androstanolone.......................................................		Mammary carcinoma
Aneurine Hydrochloride Tablets B.P..................		Any disease or condition in a pensioner
Ascorbic Acid Tablets B.P....................................		Any disease or condition in a pensioner
Bemegride Injection B.P........................................		As an antidote to barbiturate and other hypnotic poisons
Busulphan Tablets B.P...........................................		The leukaemias
Calciferol Tablets B.P............................................		Any disease or condition in a pensioner
Calciferol Solution B.P..........................................		Any disease or condition in a child under the age of twelve years or in a pensioner
Calcium Para-Aminosalicylate B.P.C.................		Tuberculosis
Caramiphen Hydrochloride..................................		Parkinsonism
Chlorambucil...........................................................		Malignant lymphoma and related conditions
Chloramphenicol Capsules B.P............................		Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
		Bacterium coli meningitis, if other forms of treatment are unsuccessful
		Brucellosis
		Granuloma inguinale
		Friedlander bacillus infections
		Haemophilus influenzae infections
		Laryngo-tracheo-bronchitis, acute
		Lymphogranuloma venereum
		Pre-operative prophylaxis
		Salmonella infections
		Staphylococcal infections
		Surgical conditions of the bowel (pre-operative and post-operative)
		Typhoid fever
		Typhus and other rickettsial diseases
		Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides
		Whooping cough (Haemophilus pertussis)
		As an alternative to the Penicillins in a person sensitive to the Penicillins
		Severe gastro-enteritis in a child under the age of sixteen years
Chloramphenicol B.P., Injection.........................		A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol B.P., Oral Suspension		A disease or condition, specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years
Chlortetracycline Capsules B.P............................		As an alternative to the Penicillins in a person sensitive to the Penicillins
		Actinomycosis
		Amoebiasis
		Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute
		Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
		Bronchiectasis

Fifth Schedule—continued.

Pharmaceutical Benefit.		Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Chlortetracycline Capsules B.P.—continued		Brucellosis
		Chancroid
		Fibrocystic disease of the pancreas
		Granuloma inguinale
		Friedlander bacillus infections
		Leptospirosis
		Lymphogranuloma venereum
		Mucoviscidosis
		Pneumonia that is resistant both to the Penicillins and the Sulphonamides
		Pre-operative prophylaxis
		Primary atypical pneumonia
		Psittacosis
		Puerperal infections
		Rat-bite fever (Spirillum minus)
		Staphylococcal infections
		Trachoma that is resistant to the Sulphonamides
		Typhus and other rickettsial diseases
		Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides
		Whooping cough (Haemophilus pertussis)
Chlortetracycline Calcium.................................................................................	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Chlortetracycline B.P. Granules
Cod Liver Oil, B.P..................................................................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Cod Liver Oil Emulsion B.P. 1953	with the written authority of the Director-General—
Corticotrophin Injection B.P.	A disease or condition specified in this a column in relation to Cortisone Injection
Corticotrophin Gelatin Injection B.P.
Corticotrophin Zinc Hydroxide Injection B.P.	The treatment of side effects of corticosteroid therapy
Cortisone Injection B.P..........................................		With the written authority of the Director-General—
		Anaemia, acquired haemolytic
		Addison’s disease and other forms of adrenocortical hypoplasia
		Adrenalectomy, total
		Adrenogenital syndrome
		Cranial arteritis
		Cushing’s syndrome, including hyperadrenocorticalism
		Dermatitis, acute exfoliative, associated with drug therapy
		Dermatomyositis
		Encephalomyelitis
		Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy
		Hansen’s disease
		Hepatitis, progressive or continuing, proven by biopsy or biochemistry
		Keratoplasty
		The leukaemias
		Nephritis, typo II.
		Nephrotic syndrome
		Neuro-myelitis optica
		Optic neuritis following removal of tumor of the brain

Fifth Schedule—continued.

Pharmaceutical Benefit.		Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Cortisone Injection B.P.—continued		Panhypopituitarism
		Pemphigus
		Periarteritis nodosa
		Pseudohermaphroditism
		Purpura, Henoch’s
		Purpura, thrombocytopenic
		Rheumatic carditis, acute
		Salaam convulsions and hypsarrythmia
		Sarcoidosis
		Scleroderma
		Splenic neutropenia and agranulocytosis
		Status asthmaticus
		Steroid therapy prior to operation in patients under steroid therapy
		Stevens-Johnson syndrome
		Still’s disease in a child under the age of sixteen years
		Sympathetic ophthalmitis
		Systemic lupus erythematosus
		Temporal arteritis
		Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
		Ulcerative colitis proven by sigmoidoscopy or radiological report
		Uveitis, posterior
Cortisone Tablets B.P.............................................		With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Cyanocobalamin Injection B.P. (other than 1,000 microgramme strength)		Established megalocytic anaemias
Cyanocobalamin Injection B.P., 1,000 microgramme strength		Neuroblastoma
Cyclosphosphamide...........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cycloserine...........................................................
D-Cycloserine.......................................................
Demethylchlortetracycline Hydrochloride		A disease or condition specified in this column in relation to Chlortetracycline Capsules
Deoxycortone Acetate B.P.............................................................................	Addison’s disease
Deoxycortone Acetate Injection B.P.
Deoxycortone Acetate Implant B.P.	Total adrenalectomy
Dexamethasone............................................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Dexamethasone Sodium Phosphate
Dextrochlorpheniramine Maleate Syrup		Any disease or condition in a child under the age of twelve years
Dienoestrol B.P., Cream........................................		Any disease or condition in a pensioner
Dienoestrol Tablets B.P.........................................		Carcinoma of the prostate
Mammary carcinoma
Any disease or condition in a pensioner
Diethyl Dithiolisophthalate...................................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Diiodohydroxyquinoline B.P., Vaginal Tablet		Trichomonal and monilial vaginitis
Dihydrostreptomycin Sulphate Injection B.P.		As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate

Fifth Schedule—continued.

Pharmaceutical Benefit.		Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act.
Dihydrotachysterol.................................................		Parathyroid deficiency
Diphenylthiourea....................................................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Disodium Diethylstilboestrol Diphosphate		Carcinoma of the prostate
Erythromycin B.P...............................................	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins
Erythromycin Tablets B.P. ...............................
Erythromycin Glucoheptonate
Erythromycin Propionate..................................
Erythromycin B.P., Oral Sachet	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins in a child under the age of twelve years
Erythromycin B.P., Oral Suspension
Erythromycin Stearate, Oral Suspension
Ethinyloestradiol Tablets B.P...............................		Turner’s syndrome
		Pre-menopausal castration
		Any disease or condition in a pensioner
Ethisterone Tablets B.P..........................................		Turner’s syndrome
		Habitual abortion
		Any disease or condition in a pensioner
Ferrous Aminoacetosulphate Syrup	Any disease or condition in a child under the age of twelve years
Ferrous Succinate Syrup............................................................................
Fludrocortisone Acetate........................................		With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Fluoxymesterone....................................................		Mammary carcinoma
Folic Acid B.P.....................................................

Macrocytic anaemia
Folic Acid Tablets B.P.......................................	Sprue or the sprue-like syndrome
Formyl-Tetrahydropteroyl Glutamic Acid		Any disease or condition in a patient receiving treatment in or at an approved hospital
Griseofulvin..............................................................		With the written authority of the Director-General—
		For the treatment of any of the following diseases, the diagnosis of which has been confirmed by pathological report:—
		Epidermorphyton floccosum
		Microsporum audouni
		Microsporum canis
		Microsporum gypseum
		Trichophyton interdigitale
		Trichophyton mentagrophytes
		Trichophyton rubram
		Trichophyton schoenleini
		Trichophyton sulphureum
		Trichophyton verrucosum
Haemophilus Influenza Bacterial Serum	Any disease or condition in a patient receiving treatment in or at an approved hospital
Hexachlorophene, 3% with Entsufon
Hexachlorophene, 3% with Lissapol
Hexachlorophene, 1.5% with Soap Solution
Hydrocortisone Injection B.P................................		With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Sodium Succinate B.P.		With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Hydrocortisone Sodium Succinate Injection B.P.		Acute adrenal failure due to a medical or surgical crisis
		Stevens-Johnson syndrome
Iron Oxide Saccharated.........................................		As an alternative to Oral Iron in a person unable to take Oral Iron

Fifth Schedule—continued.

Pharmaceutical Benefit.		Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Isoniazid Tablets B.P..............................................		Hansen’s disease
		Tuberculosis
Levorphanol Tartrate B.P.C..................................		Inoperable cancer
Lofenalac.................................................................		With the written authority of the Director-General, phenylketonuria
Malt Extract B.P.............................................................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Malt Extract with Cod Liver Oil B.P.
Mercaptopurine Tablets B.P..................................		The leukaemias
Methicillin.................................................................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Methotrexate...........................................................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Methyl Androstanolone.........................................		Mammary carcinoma
Methylandrostenediol............................................		Senile osteoporosis proven by radiography
Mustine Injection B.P.............................................		Malignant lymphoma and related conditions
Neomycin Sulphate B.P., in a form other than Eye Drops		Any disease or condition in a patient receiving treatment in or at an approved hospital
Nicotinamide Tablets B.P......................................		Any disease or condition in a pensioner
Nicotinic Acid Tablets B.P....................................		Any disease or condition in a pensioner
Nitrofurantoin..........................................................		Urinary tract infections
Nitromin....................................................................		Malignant lymphoma and related conditions
Norethandrolone.....................................................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Calcium B.P...................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Sodium B.P.....................................
Novobiocin Tablets B.P.....................................
Nystatin....................................................................		Proven monilia infections
Oxytetracycline Tablets B.P.	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Oxytetracycline Injection B.P.
Oxytetracycline and Procaine Injection B.P.
Calcium Di-Oxytetracycline.................................		A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Pancreatin B.P.........................................................		Fibrocystic disease of the pancreas
		Pancreatico-duodenectomy
Pancrex 5..................................................................		Fibrocystic disease of the pancreas
		Pancreatico-duodenectomy
Para-Aminosalicylic Acid......................................		Tuberculosis
Pethidine and Levallorphan Tartrate..................		Obstetrical use
Phenoxymethylpenicillin B.P., Oral Suspension	Any disease or condition in a child under the age of twelve years
Phenoxymethylpenicillin (Benzathine Salt), Oral Suspension
Phenoxymethylpenicillin Calcium B.P., Oral Suspension
Phenoxymethylpenicillin (Hydrabamine Salt), Oral Suspension
Phenoxymethylpenicillin Potassium B.P., Oral Suspension
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.		Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Phytomenadione Injection B.P.............................		Antidote to anticoagulants
Piperazine Citrate B.P., Elixir...............................		Any disease or condition in a child under the age of twelve years
Prednisolone Disodium Phosphate......................		With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report

Fifth Schedule—continued.

Pharmaceutical Benefit.		Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Prednisolone Tablets B.P.......................................		With the written authority of the Director-General—
		Anaemia, acquired haemolytic
		Adrenogenital syndrome
		Cranial arteritis
		Cushing’s syndrome, including hyperadrenocorticalism
		Dermatitis, acute exfoliative, associated with drug therapy
		Dermatomyositis
		Encephalomyelitis
		Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy
		Hansen’s disease
		Hepatitis, progressive or continuing, proven by biopsy or biochemistry
		The leukaemias
		Nephritis, type II.
		Nephrotic syndrome
		Neuro-myelitis optica
		Optic neuritis following removal of tumour of the brain
		Panhypopituitarism
		Pemphigus
		Periarteritis nodosa
		Pseudohermaphroditism
		Purpura, Henoch’s
		Purpura, thrombocytopenic
		Rheumatic carditis, acute
		Salaam convulsions and hypsarrythmia
		Sarcoidosis
		Scleroderma
		Splenic neutropenia and agranulocytosis
		Status asthmaticus
		Steroid therapy prior to operation in patients under steriod therapy
		Still’s disease in a child under the age of sixteen years
		Sympathetic ophthalmitis
		Systemic lupus erythematosus
		Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
		Ulcerative colitis proven by sigmoidoscopy or radiological report
		Uveitis, posterior
Methyl Prednisolone...............................................................		With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisolone Acetate B.P..................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisolone Sodium Hemisuccinate		Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisone Tablets B.P............................................................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.

Fifth Schedule—continued.

Pharmaceutical Benefit.		Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Progesterone Injection B.P....................................		Habitual abortion
Protoveratrines A....................................................		Hypertensive crisis
Pyrazinamide...........................................................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridine Aldoxime Methiodide............................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridostigmine Injection B.P................................		Myasthenia gravis
Pyridostigmine Tablets B.P...................................		Myasthenia gravis
Riboflavine Tablets B.P.........................................		Any disease or condition in a pensioner
Ristocetin..................................................................		Any disease or condition in a patient receiving treatment in or at an approved hopital
Salicylazosulphapyridine......................................		Ulcerative colitis
Sobee.........................................................................		With the written authority of the Director-General, galactosaemia
Sodium Aminosalicylate B.P.	Tuberculosis
Sodium Aminosalicylate Tablets B.P.
Sodium Folate.........................................................		Macrocytic anaemia
		Sprue or the sprue-like syndrome
Spironolactone........................................................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Stilboestrol B.P..................................................	Carcinoma of the prostate
Stilboestrol Tablets B.P..............................................................................	Mammary carcinoma
	Any disease or condition in a pensioner
Streptomycin Sulphate B.P....................................		Bacillary dysentery that is resistant to the Sulphonamides
		Brucellosis
		Chancroid
		Endocarditis due to Streptococcus faecalis or Streptococcus viridans
		Friedlander bacillus infections
		Haemophilus influenzae infections
		Plague
		Pseudomonas pyocyaneus infections
		Rat-bite fever (Streptobacillus moniliformis)
		Salmonella infections
		Surgical conditions of the bowel (pre-operative and post-operative)
		Surgical conditions of the thoracic organs
		Tuberculosis
		Tularaemia
		Urinary tract infections that are resistant to the Sulphonamides
Streptomycin Sulphate Injection B.P...................		A disease or condition specified in this column in relation to Streptomycin Sulphate
Streptomycin Sulphate B.P. with Benzylpenicillin Sodium, B.P.		Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Sulphadimethoxine Suspension...........................		Any disease or condition in a child under the age of twelve years
Sustanon................................................................	Castration
Testosterone Implants B.P..................................	Mammary carcinoma
Testosterone Oenanthate....................................
Testosterone Propionate Injection B.P.	Castration
Testosterone Propionate B.P.	Kline felter Reifenstein Albright sydrome
Methyltestosterone Tablets B.P.	Mammary carcinoma
Tetracycline with a buffering agent and Amphotericin B		Broad spectrum antibiotic therapy of premature infants

Fifth Schedule—continued.

Pharmaceutical Benefit.		Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Tetracycline Capsules B.P....................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Tetracycline Tablets B.P.......................................
Tetracycline and Procaine Injection B.P.
Tetracycline Hydrochloride B.P. with a buffering agent—Capsules
Tetracycline with Oleandomycin Capsules
Pyrrolidino-Methyl-Tetracycline
Tetracycline Hydrochloride B.P.	A disease or condition, specified in this column in relation to Chloretracycline Capsules, in a child under the age of twelve years
Tetracycline Hydrochloride B.P. with a buffering agent—Oral Suspension
Tetracycline Hydrochloride B.P. with a buffering agent—Paediatric Drops
Tetracycline with Oleandomycin—Oral Suspension
Tetracycline Hydrochloride B.P. with Nystatin		Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
		A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules
Thyrotropin....................................................................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Triamcinolone...............................................................		With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Triethylene Thiosphosphoramide.............................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Tretamine.......................................................................		Malignant lymphoma and related conditions
Trifluoperazine..............................................................		Any disease or condition in a pensioner
Trimetaphan Camphorsulphonate.............................		Hypotensive for anaesthesia
Triprolidine Hydrochloride, Elixir.............................		Any disease or condition in a child under the age of twelve years
Veriloid...........................................................................		Hypertensive crisis
Vitamin A Activity with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D		Any disease or condition in a pensioner
Concentrated Vitamin A Solution B.P.	Any disease or condition in a child under the age of twelve years or in a pensioner
Concentrated Vitamin A and D Solution B.P.
Concentrated Vitamin D Solution
Vitamin K.......................................................................		As an antidote to anticoagulants

 

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.